Baudouin-Legros M, Dard B, Guicheney P, Meyer P
Department of Pharmacology, INSERM U7, Hôpital Necker, Paris, France.
J Cardiovasc Pharmacol. 1987 Sep;10(3):287-92. doi: 10.1097/00005344-198709000-00006.
We studied the effect of nicardipine on the release of preincorporated tritiated serotonin (5-HT) from washed rat platelets and on platelet 5-HT uptake. Nicardipine exerted a complex action. It partially antagonized thrombin-induced 5-HT secretion, but also induced the "selective" release of 5-HT without concomitant ATP release in the absence of platelet activation and inhibited active 5-HT uptake. The two latter effects were observed in the presence of EGTA and therefore could not be related to calcium channel blockade. Verapamil, TMB 8, and the calmodulin antagonists trifluoperazine and R 24571 also possessed this multiplicity of action; however, verapamil and TMB 8 were weaker inducers of selective 5-HT release and uptake inhibition. These results show that, in addition to its inhibitory effect on thrombin-induced platelet activation, nicardipine inhibits platelet 5-HT accumulation. Its administration may therefore result in 5-HT depletion.
我们研究了尼卡地平对经洗涤的大鼠血小板中预先掺入的氚标记血清素(5-羟色胺,5-HT)释放以及对血小板5-HT摄取的影响。尼卡地平发挥了复杂的作用。它部分拮抗凝血酶诱导的5-HT分泌,但在无血小板激活的情况下也能诱导5-HT的“选择性”释放且不伴有ATP释放,并抑制5-HT的主动摄取。后两种效应在存在乙二醇双四乙酸(EGTA)的情况下观察到,因此与钙通道阻滞无关。维拉帕米、TMB 8以及钙调蛋白拮抗剂三氟拉嗪和R 24571也具有这种多种作用;然而,维拉帕米和TMB 8作为选择性5-HT释放和摄取抑制的诱导剂作用较弱。这些结果表明,除了对凝血酶诱导的血小板激活具有抑制作用外,尼卡地平还抑制血小板5-HT的蓄积。因此,其给药可能导致5-HT耗竭。